We are live on ! Find out more
PLSE icon

Pulse Biosciences

31 hedge funds and large institutions have $5.28M invested in Pulse Biosciences in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more capital invested

Capital invested by funds: $4.38M → $5.28M (+$892K)

1.68% less ownership

Funds ownership: 8.26%6.58% (-1.7%)

30% less funds holding

Funds holding: 4431 (-13)

50% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 12

80% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 15

Holders
31
Holders Change
-13
Holders Change %
-29.55%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
12
Closed
15
Calls
$1.29M
Puts
Net Calls
+$1.29M
Net Calls Change
+$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
1
Bank of America
North Carolina
$1.77M +$317 +195 +0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.3M -$39.4K -24,291 -4%
BlackRock
3
BlackRock
New York
$513K -$1.52K -935 -0.4%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$306K
GAM
5
Griffin Asset Management
New York
$197K +$28.2K +17,383 +25%
Northern Trust
6
Northern Trust
Illinois
$171K +$3.44K +2,117 +3%
State of Wisconsin Investment Board
7
State of Wisconsin Investment Board
Wisconsin
$148K -$30.5K -18,800 -23%
SAG
8
Spotlight Asset Group
Illinois
$147K +$108K +66,425 New
Millennium Management
9
Millennium Management
New York
$135K -$100K -61,685 -51%
State Street
10
State Street
Massachusetts
$117K
Osaic Holdings
11
Osaic Holdings
Arizona
$113K +$35.7K +21,975 +81%
E
12
Ergoteles
New York
$85K -$44.8K -27,587 -43%
TF
13
TIAA FSB
Florida
$63K
LCS
14
Levin Capital Strategies
New York
$46K
Morgan Stanley
15
Morgan Stanley
New York
$39K -$457K -281,593 -94%
AGM
16
Alpine Global Management
New York
$28K
BFM
17
Boothbay Fund Management
New York
$28K
Qube Research & Technologies (QRT)
18
Qube Research & Technologies (QRT)
United Kingdom
$27K -$2.63K -1,620 -12%
Wells Fargo
19
Wells Fargo
California
$19K -$388 -239 -3%
Citigroup
20
Citigroup
New York
$10K +$7.11K +4,376 +3,529%
Group One Trading
21
Group One Trading
Illinois
$6K +$4.45K +2,742 New
TCWA
22
Ten Capital Wealth Advisors
Washington
$5K
Carson Wealth (CWM LLC)
23
Carson Wealth (CWM LLC)
Nebraska
$2K
OCM
24
Osterweis Capital Management
California
$2K +$1.62K +1,000 New
BNP Paribas Financial Markets
25
BNP Paribas Financial Markets
France
$1.74K -$2.35K -1,445 -66%

PLSE Hedge Fund Activity: Q3 2022 in Review

31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2022, worth a combined $5.28M — up 20% from $4.38M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of PLSE and 3 opened new positions — a net loss of 12 holders — while 12 trimmed existing stakes and 6 added.

The largest buyer was Osaic Holdings, adding an estimated $35.7K. The largest seller was Morgan Stanley, cutting an estimated $457K.

  • 31 institutional investors held Pulse Biosciences (PLSE) as of Q3 2022, down from 44 in Q2 2022.
  • Funds reported $5.28M of Pulse Biosciences stock for Q3 2022, up 20% quarter-over-quarter.
  • 3 funds opened new Pulse Biosciences positions in Q3 2022 and 15 closed out, a net change of -12 holders.
  • The largest Pulse Biosciences buyer in Q3 2022 was Osaic Holdings, an estimated $35.7K added.
  • The largest Pulse Biosciences seller in Q3 2022 was Morgan Stanley, an estimated $457K sold.

Based on aggregated 13F filings for Q3 2022.